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Stress responseMitochondria represent the major bioenergetic hub coordinating cellular and organismal homeostasis. The un-
derlying causes of many pathologies tormenting humans converge on impaired mitochondrial maintenance.
Mitochondria-speciﬁc autophagy (mitophagy), a cellular catabolic process targetingmitochondria, holds a prom-
inent role inmitochondrial quality control. In addition to core autophagicmachinery components,mitophagy ex-
ploits a variety of molecules that identify damaged or superﬂuous mitochondria and mediate their elimination.
Signaling pathways integrating environmental and genetic stimuli interact with key mitophagy effectors to acti-
vate cellular stress responsemechanisms, ultimatelymodulating health and lifespan. Here, we review the signal-
ing cascades and molecular mechanisms that govern the process of mitophagy and discuss their involvement in
ageing and neurodegeneration. This article is part of a Special Issue entitled:Mitochondrial Dysfunction in Aging.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria, the energy-generating organelles in eukaryotic cells,
play essential roles in fundamental cellular processes, such as the supply
of metabolic intermediates supporting biosynthetic and bioenergetic
needs of the cell [1], apoptosis [2], calcium (Ca2+) homeostasis [3,4]
and cell signaling [5], among others. Accumulating evidence indicates
that mitochondria can signal between cells so as perturbations in
mitochondrial function in one tissue can be sensed over considerable
distances by other tissues. It is not surprising, therefore, that mitochon-
dria can impinge on cellular stress response pathways, modulating
metabolism, cell survival and organismal healthspan.
Research in the ﬁeld of ageing, in the past few years, has culminated
in the identiﬁcation of an intriguing link between autophagy and mito-
chondrial function with wide-ranging implications in health and
disease [6,7]. A selective form of autophagy, known as mitophagy, that
speciﬁcally targets damaged or superﬂuous mitochondria for autopha-
gic degradation [8,9], has been repeatedly shown to participate in
the maintenance of a healthy mitochondrial population. Defects inndrial Dysfunction in Aging.
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arakis).mitophagy have been associated with decreased neuronal function
and increased susceptibility to neurodegeneration, during ageing [8,
10]. Here, we review the recent advances on the intricate connections
between mitochondria and autophagy, focusing on the molecular
mechanisms that mediate mitophagy. Furthermore, we discuss how
compromised mitophagy affects neuronal function, contributing to the
onset and progression of several neurodegenerative diseases during
ageing.2. Mitochondria: The basics
Mitochondria, like their bacterial ancestors, are bounded by two
functionally distinct membranes, an outer (OM) and an inner mem-
brane (IM) that is highly folded into cristae. These two membranes
give rise to two separate aqueous compartments, the intermembrane
space and the internal matrix space. Mitochondria contain their own
circular genome of alpha-proteobacterial origin, the mitochondrial
DNA (mtDNA) organized into nucleoids in thematrix (Fig. 1). High res-
olution electron micrographs of mouse and human nucleoids revealed
that most of them are located inside mitochondrial tubes. One part of
nucleoids is linked to inner membranes of cristae, while the other part
is bound to the complexes that cross cut both mitochondrial mem-
branes [11]. Individual cells have a varying copy number of mtDNA de-
pending on cell type and interestingly, they can carry both normal and



































Fig. 1. Linking signal transduction cascades that inﬂuence ageing with mitochondrial regulatory mechanisms. Mitochondrial ROS levels are tightly controlled by several mechanisms. For
example, UCPs prevent the reduction of molecular oxygen to superoxide by lowering the mitochondrial membrane potential (ΔΨm). Generation of low levels of mitochondrial ROS par-
ticipate in the regulation of cellular signaling pathways thatmediate stress resistance, thereby enhancing longevity. On the contrary, excessive ROSproduction leads tomitochondrial dam-
age. Damaged mitochondria can be degraded by autophagy, which is induced by caloric restriction, among others. Mitophagy, selective degradation of dysfunctional mitochondria,
depends on speciﬁc cargo receptors, such as p62. ROS production can also activate the tumour suppressor protein p53, which in turn, may induce autophagy through its transcriptional
activity. On the other hand, cytoplasmic p53 suppresses autophagy. ROS cause damage toDNA, proteins and lipids. Arrows indicate stimulatory inputs. Bars indicate inhibitory interactions.
For clarity, some of the signaling connections are not shown. ROS, reactive oxygen species; TOR, target of rapamycin; Ub, ubiquitin; UCPs, uncoupling proteins; V-ATPase, vac-
uolar H+-ATPase.
1413E. Lionaki et al. / Biochimica et Biophysica Acta 1847 (2015) 1412–1423MammalianmtDNAencodes 13mitochondrial proteins, synthesized
by a separate translation machinery, as well as two mitochondrial
ribosome-coding RNAs and 22 transfer RNAs. Mitochondrial-encoded
proteins play essential roles in regulation of cellular bioenergetics. In
addition to mitochondrial-encoded proteins, the organelle activities
rely on over 1000 nuclear-encoded proteins, including gene products
required for mtDNA replication, transcription and DNA repair. These
proteins translocate from the cytosol into the inner mitochondrial
membrane and the matrix [13]. Five import pathways cooperate with
each other and synergize with other proteins that function in the respi-
ratory chain, mitochondrial membrane organization, protein quality
control and endoplasmic reticulum-mitochondria junctions so as to
form an interconnected network of machineries harnessed for various
mitochondrial functions [14].mtDNA ismaternally inherited as paternal
mtDNA and the sperm-derived mitochondria disappear during early
embryogenesis in many eukaryotes. Recent studies have demonstrated
that elimination of paternal mitochondria, immediately after fertiliza-
tion, is mediated by the recruitment of autophagosomes around
sperm mitochondria, leading to their lysosomal degradation in both
the nematode Caenorhabditis elegans and in the mouse [15,16]. Later
work has indicated that a network of multi-vesicular body-like struc-
tures related to the endocytic and autophagic pathways is responsible
for the destruction of paternal mitochondria in Drosophila melanogaster
[17].
It is well established that ageing is associated with progressive
accumulation of mutations/deletions in nuclear and mitochondrial
genomes and is becoming increasingly clear that increased mtDNA
mutagenesis can lead to premature ageing [18]. Indeed, homozygous
knock-in mtDNA mutator mice expressing a defective nuclear-encoded mitochondrial DNA polymerase have reduced lifespan and
develop various premature ageing phenotypes [19].
3. Mitochondria as determinants of cellular and
organismal energetics
Mitochondria are the sites of adenosine triphosphate (ATP) produc-
tion via oxidative phosphorylation (OXPHOS) taking place in the elec-
tron transport chain (ETC). ETC consists of multi-subunit protein
complexes embedded in the innermembrane. Electrons are transferred
through complexes I–IV to the ﬁnal electron acceptor oxygen. In the
ﬁnal step, the terminal enzyme of the respiratory chain, cytochrome c
oxidase (complex IV) catalyzes the complete reduction of molecular
O2 to water. In 1961, Peter Mitchell proposed the mechanism of cou-
pling electron transport to ATP production, the so called chemiosmotic
theory of oxidative phosphorylation, for which he was awarded the
Nobel Prize in chemistry in 1978 [20]. Accordingly, the energy derived
from the transfer of electrons across complexes I, III and IV of the ETC
is coupled to a proton gradient established across the inner mitochon-
drial membrane through pumping of protons from thematrix to the in-
termembrane space. As the proton gradient becomes large enough,
protons tend to return to the matrix via the ATP synthase (complex
V), which consists of two structurally distinct rotary motors, F0 and F1.
The F0 subunit is embedded in the membrane and provides a channel
through which protons can ﬂow back from the intermembrane space
to the matrix. The F1 subunit uses the energetically favorable proton
ﬂow through the F0 for the phosphorylation of ADP to ATP [21,22]. It is
worth noting that, two decades later, the Nobel Prize in chemistry was
again awarded for ground-breaking work regarding the elucidation of
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E. Walker) and the discovery of the enzyme sodium, potassium-
stimulated adenosine triphosphatase (Jens C. Skou) [23–26].
Besides ATP, mitochondria also produce intermediate metabolites
and reducing agents, such as nicotinamide adenine dinucleotide
(NADH) and ﬂavin adenine dinucleotide (FADH2), via the tricarboxylic
acid cycle (TCA) in thematrix [27]. Given that TCA cycle and ETC require
NAD and NADH respectively, an optimal NAD/NADH ratio is necessary
for the mitochondrion to function properly [28,29]. Interestingly,
emerging ﬁndings suggest that the mitochondrial NAD pool per se is
essential for maintaining optimal mitochondrial function in different
tissues [30]. Moreover, the metabolites generated in the TCA cycle are
used in important biosynthetic reactions, such as nucleotide biosynthe-
sis, lipid biosynthesis, amino acid biosynthesis, among others. Mito-
chondria also play a crucial role in ketone body production, urea cycle,
heme biosynthesis and fatty acids β-oxidation. Apart from their impor-
tant biosynthetic functions, mitochondria are well known for their
contribution in reactive oxygen species (ROS) generation through respi-
ration and other enzyme- or metal-catalyzed reactions [31–33]. A
wealth of reports in the literature have established that excessive ROS
attack macromolecules (nucleic acids, proteins and lipids), and there-
fore the balance between oxidant species and anti-oxidant defense
determines the consequences of oxidative damage for the cell and the
organism. ROS generation is believed to be inﬂuenced by themitochon-
drial membrane potential and oxygen availability [34]. Studies in both
invertebrate and vertebrate model systems have shown that mitochon-
drial ROS are overproduced andmtDNAdamage increaseswith age [35].
Excessive ROS generation has been implicated in ageing and a variety of
diseases, such as metabolic syndromes, obesity, diabetes, cardiomyopa-
thies, cancer as well as in various neurodegenerative diseases [36–38].
4. Mitochondrial quality control mechanisms integrate with signal
transduction cascades that inﬂuence health and lifespan
Recent studies inmodel organisms led to the intriguing concept that
mitochondrial ROS function as signalingmolecules to modulate distinct
cellular processes, including stem cell proliferation, differentiation and
senescence, autophagy, innate immune responses and epigenetics
[39–41]. Subsequently, accumulating evidence has questioned the free
radical theory of ageing according to which intracellular oxidants, gen-
erated mainly by mitochondria in the course of normal metabolism,
play a key role in the ageing process [34,42–45]. Thus, it has been
assumed that various lifespan-prolonging interventions, such as caloric
restriction (CR), glucose restriction and physical exercise are linked, at
least in part, with an increase inmitochondrial ROS production. Accord-
ingly, it was reported that low levels of ROS can improve cellular de-
fense mechanisms and activate stress response pathways (a strategy
known as mitohormesis) [46] that ultimately enhance the cellular and
organismal ﬁtness and promote longevity in yeast, C. elegans and mice
[47–49].
Impaired mitochondrial function caused by mutations or reduced
function of nuclear-encoded ETC components, among others, has also
been reported to activate the mitochondrial unfolded protein response
(UPRmt). This is a signaling cascade that increases, among others, the ex-
pression of nuclear-encoded mitochondrial proteins, such as chaper-
ones and proteases, in order to restore mitochondrial function. The
UPRmt responds to cell-autonomous and cell-non-autonomous cues.
Notably, neuronal speciﬁc knockdown of the nuclear-encoded cyto-
chrome c oxidase-1 subunit Vb/COX4 (cco-1) was able to upregulate
UPRmt in the intestine, leading to lifespan extension in nematodes
[50]. However, the molecular mediators of systemic signaling are yet
to be deﬁned.
Recent evidence has indicated that the activation of UPRmt depends
on the activating transcription factor associatedwith stress-1, ATSF-1 in
C. elegans. Notably, ATSF-1 has both a nuclear localization signal (NLS)
and a mitochondrial targeting sequence (MTS). In the absence ofstress, ATSF-1 is imported into mitochondria and degraded. However,
mitochondrial stress promotes the accumulation of ATSF-1 in the nucle-
us, where it mediates gene expression changes producing beneﬁcial
effects on longevity [51]. Research in ﬂies and mice further suggest
that UPRmt is a hitherto unrecognized evolutionarily conserved defense
mechanism that regulates whole organism longevity following mito-
chondrial perturbation [52,53]. These studies support the evolving role
of mitochondria as signaling organelles that communicate with the
rest of the cell under both physiological and pathophysiological condi-
tions, thereby inﬂuencing cellular and organismal homeostasis.
In apparent contrast to the above mentioned lifespan extension
conferred by mild mitochondrial dysfunction, severe mitochondrial
damage has been repeatedly linked to the ageing process and the devel-
opment of various diseases. It is not surprising, therefore, that numerous
studies have focused on elucidating the mechanisms that contribute to
maintenance or restoration of mitochondrial function.
5. Uncoupling proteins (UCPs) in the regulation of
mitochondrial function
Accumulating ﬁndings in recent years argue for mitochondrial pro-
duction of ROS being tightly controlled. Uncoupling proteins (UCPs)
1–3, which are mitochondrial anion carriers, appear to play an essential
role in preventing the reduction of molecular oxygen to superoxide by
lowering the mitochondrial membrane potential (Fig. 1). However,
the molecular mechanisms by which UCPs regulate ROS levels in
mitochondria remain elusive. Current evidence suggests that ROS and
ROS derivatives activate UCPs, which, in turn, induce a mitochondrial
proton leak from the intermembrane space to the matrix, thereby pro-
viding a negative feedback mechanism that mitigates ROS production.
UCP2 and UCP3, in particular, seem to be controlled by reversible S-
glutathionylation in response to changes in ROS production and inmito-
chondrial membrane potential [54]. Together, these ﬁndings provide
new mechanistic insight into the regulation of mitochondrial ROS
emission, placing emphasis on the role of UCPs. Interestingly, UCP2
might be considered as neuroprotective due to its ability to block the
release of apoptogenic factors, when activated. Speciﬁcally, it has been
shown that the overexpression of human UCP2 in mice reduces brain
damage induced by experimental stroke and enhances neurological
recovery. In addition, UCP2 prevents the activation of caspase-3 under
conditions of oxygen and glucose deprivation in cultured cortical
neurons [55]. On the other hand, UCP1 reportedly plays an essential
role in thermogenesis in brown adipose tissue (BAT) and in white
adipose tissue (WAT) in response to cold. To this end, UCP1 stimulates
ETC activity, resulting in oxidation of available substrates and conse-
quently in heat generation [56]. A latest study reports that Zfp516
acts as a transcriptional activator of both UCP1 and the proliferator-
activated receptor gamma, coactivator 1 alpha (PGC1a). Upon exposure
to cold, Zfp516 binds to the proximal region of UCP1 promoter, thus ac-
tivating a BAT program that is crucial for survival in cold environments.
Moreover, Zfp516 overexpression in adipose tissue leads to browning of
WAT even at ambient temperature and importantly prevents diet-
linked obesity [57]. The emerging role of mitochondria in WAT homeo-
stasis, and their involvement in whole organism homeostasis thereof
has recently attracted considerable attention.
6. Mitochondria: Autophagy and more
As brieﬂy mentioned above, several recent studies have revealed an
intriguing link between mitochondria and autophagy. Macroautophagy
(hereafter, autophagy) is amajor catabolic pathway bywhich eukaryot-
ic cells degrade long-lived proteins, damaged or excess organelles or
portions of the cytoplasm. During autophagy, cargoes to be degraded
are engulfed in double-membrane vesicles, the autophagosomes. This
is followed by fusion of autophagosomes with lysosomes to form
autolysosomes, in which the sequestered material is degraded and
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the Golgi apparatus, the plasma membrane and mitochondria have all
been shown to contribute to autophagosome biogenesis [59].
Autophagy serves housekeeping functions under normal conditions
being maintained at basal levels. As such, it is essential for survival, de-
velopment and homeostasis at both the cellular and whole organism
level. However, autophagy is activated under stress, such as nutrient
and growth factor deprivation, oxidative damage, hypoxia or anoxia,
ER stress, invasion of pathogens, to serve predominantly cytoprotective
functions. Several studies in the last few years have revealed the exis-
tence of strong connections between autophagy and the cellular energy
balance [60–62]. In this regard, mitochondria appear to play a key role
in starvation-induced autophagy, supplying membranes for the forma-
tion of autophagosomes [63]. Furthermore, autophagosome biogenesis
in response to starvation depends on the tethering activity of mitofusin
2 (MFN2), a core component of the mitochondrial fusion machinery. In
addition to its role in mitochondrial fusion, MFN2 has also been shown
to mediate tethering of mitochondria to ER. MFN2 depletion prevents
the activation of autophagy in human cancer cell lines during starvation
[64].
Although autophagy is generally considered to be a non-selective
process thatmediates the bulk degradation of cytoplasmic components,
accumulating evidence has clearly shown that it can also speciﬁcally
target damaged or superﬂuous organelles, such as mitochondria
(mitophagy) [65], peroxisomes (pexophagy) [66], ER (ER-phagy) [67],
lipid droplets (lipophagy) [68] or invading bacteria (xenophagy),
among others [69] for degradation. Selective autophagy requires recep-
tors that link speciﬁc cargoes to the microtubule associated protein 1
light chain-3 (LC3)/GABARAP/GATE-16 proteins, homologous to the
Saccharomyces cerevisiae Atg8 [70,71]. LC3 localizes to membranous
structures appearing during formation of the autophagosome [72].
Mitophagy has received much attention for its role as a mitochondrial
quality control mechanism that eliminates defective mitochondria to
maintain a healthy mitochondrial network, thus contributing to cell
viability and whole organism healthspan. A recent study has revealed
a role for cardiolipin, a phospholipid unique to the mitochondrial
IM, in a mitochondrial “eat me” signaling process that leads to
autophagosome recruitment around damaged mitochondria for degra-
dation. Speciﬁcally, externalization of cardiolipin to the outermitochon-
drial membrane in response to extrinsic stimuli such as rotenone,
staurosporine and 6-hydroxydopamine known to cause serious damage
tomitochondria, facilitates the recognition of defectivemitochondria by
the autophagy pathway in primary cortical neurons and SH-SY5Y cells.
Interestingly, the LC3 protein contains cardiolipin-binding sites. These
sites are required for autophagy activation [73]. In this regard, it should
be noted that autophagy is particularly essential formaintaining cellular
homeostasis in terminally differentiated cells such as cardiomyocytes
and neurons. Compelling evidence from studies in yeast suggests that
general autophagy and mitophagy are regulated independently for
one another [8,74,75].
6.1. Mitochondrial ROS and autophagy
Accumulating evidence suggests an interesting link between ROS
production and autophagy regulation [76,77]. Remarkably, HeLa cells
deﬁcient in ETC function (HeLa ρ° cells) as well as Hela cells overex-
pressingmanganese superoxide dismutase 2 (SOD2) fail to increase su-
peroxide (O2−) production under starvation. Moreover, these cells are
not able to activate 5′ adenosine monophosphate-activated protein ki-
nase (AMPK) and thereof starvation-induced autophagy [78]. Taken to-
gether, these observations support the idea that ROS play an essential
role in the regulation of autophagy during starvation.
Along similar lines, recent studies have revealed other molecular
players involved in the complex interplay between ROS and autophagy.
For example, oxidative stress, among others, can activate the tumour
suppressor protein p53 that is able to trigger autophagy through itstranscriptional activity, while it has been shown to inhibit autophagy
through its cytoplasmic, not nuclear functions. As a transcription factor,
p53 transactivates genes that activate autophagy, such as damage-
regulated autophagy modulator (DRAM), sestrins-1 and -2 and unc-
51-like kinase 1 (ULK1), among others. In turn, autophagy induction
leads to ROS suppression [79]. In contrast to the above mentioned p53
targets that activate autophagy, the p53 inducible protein TIGAR,
which functions as a fructose-2,6 biphosphatase, contributes to sup-
pression of intracellular ROS and inhibits autophagy. Therefore, TIGAR
seems to affect autophagy through ROS regulation [80]. On the other
hand, cytoplasmic p53 suppresses autophagy by inhibiting AMPK, a
positive regulator of autophagy, which in turn, activates mammalian
target of rapamycin (mTOR), thereby inhibiting autophagy (Fig. 1)
[81,82]. However, the precise mechanism through which cytoplasmic
p53 exerts its inhibitory effects on autophagy still remains elusive.
Although our understanding of the complex crosstalk between
autophagy and ROS is rapidly expanding, one of the main questions in
the area is how ROS regulate the autophagic activity. Increasing
evidence supports the idea that ROS can reversibly oxidize and reduce
speciﬁc amino acids, most frequently reactive Cys residues, but also
Met residues, thereby activating or inactivating their targets proteins.
As a consequence, ROS canmodulate various intracellular pathways, in-
cluding autophagy. In particular, the essential autophagy protein ATG4
seems to be one of the Cys-dependent proteases targeted bymitochon-
drial ROS under nutrient deprivation conditions. Indeed, starvation in-
duces autophagy and reportedly increases H2O2 in mitochondria. The
link between mitochondrial ROS production and autophagy requires,
at least in part, the redox-dependent inactivation of ATG4, which
inhibits delipidation of the microtubule-associated light chain 3(LC3),
thus increasing autophagosome formation [83]. Interestingly, a similar
requirement has been recently reported for peroxisome-derived ROS,
which are able to repress mammalian target of rapamycin complex 1
(mTORC1) and induce autophagy [84].
Collectively, ROS can induce autophagy, which in turn dampens
oxidative damage, serving a cytoprotective function [83,85]. Readers
are referred to recent comprehensive reviews focusing on the role of
ROS in the regulation of autophagy and further discussing the com-
plex crosstalk between autophagy and oxidative stress [37,85,86].
7. Mitochondrial dynamics and autophagy: An intricate crosstalk
Mitochondria are dynamic organelles that divide, fuse, migrate and
undergo turnover. All these processes are tightly regulated so as tomod-
ulate mitochondrial function in response to physiological or stressful
stimuli [87], therebymeeting the energy demands at cellular and organ-
ismal levels. Accumulating ﬁndings indicate that mitochondrial fusion
and ﬁssion play a crucial role in regulating mitochondrial function. In-
deed, mutations in MFN2 and OPA1 (optic atrophy gene 1) dynamin-
related GTPases that mediate mitochondrial outer membrane and
innermembrane fusion respectively, are associatedwithdiseases affect-
ing several tissues beyond the optic and peripheral nerves. Like inhibi-
tion of mitochondrial fusion, ﬁssion inhibition can negatively impact
mitochondrial function by preventing equal segregation of mitochon-
dria into daughter cells during cell division or more importantly by in-
terfering with autophagy and consequently preventing the elimination
of damaged mitochondria [87]. A subsequent study has revealed that
mitochondria elongate under nutrient deprivation. Under these condi-
tions of increased energy requirement, elongated mitochondria escape
from autophagic degradation and maintain ATP production, thereby
promoting cell survival [88].
Consistentwith the idea thatmitochondrial dynamics interfacewith
mitophagy, a deﬁciency in ﬁssion-mediated proteins such as the
dynamin-like protein DRP1 or FIS1 blocks mitochondrial autophagy
leading to accumulation of oxidized mitochondrial proteins that com-
promise the respiratory chain activity and impair insulin secretion in in-
sulin secreting INS-1 cells. Similarly, OPA1-overexpression increases
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point at an intriguing interplay between autophagy and mitochondria
with important implications for ageing and mitochondria-linked
diseases [32,91–95].
7.1. The PINK1/Parkin pathway
The PINK1/Parkin pathway is the most well-studied pathway medi-
ating selective autophagy of damaged mitochondria. This pathway acts
as a hub for coordinated regulation of several processes that promote ef-
ﬁcient mitochondrial removal, like mitochondrial dynamics, trafﬁcking
and recruitment of components of the autophagic machinery. Mecha-
nistic insights into the regulation of the core players of this pathway
have emerged in the literature and are described below.
Parkin is a RING In Between RING (RBR) E3 ligase. Structurally, it
consists of an N-terminal Ubiquitin-like domain (UblD), three RING-
ﬁnger domains, RING0, RING1 and RING2, and a Cysteine-rich In Be-
tween RING domain (IBR) lying between RING1 and RING2 (Fig. 2A).
Under physiological conditions, Parkin exists in the cytoplasm in an
autoinhibited state [96,97]. Parkin mitochondrial recruitment depends
on the stabilization of Phosphatase and tensin homolog (PTEN)-induced
putative kinase 1 (PINK1) on the outer membrane of depolarized
mitochondria, both in mammals and in D. melanogaster [98–101]. In
healthy mitochondria, the serine/threonine kinase PINK1 is continually
imported into the inner mitochondrial membrane, in a potential-
dependent manner (Fig. 2B). It is processed into a 60 kDa form by the
Mitochondrial Processing Peptidase (MPP) [102] and then cleaved
between alanine-103 and phenylalanine-104 residues giving rise to an
unstable 52 kDa fragment. The cleavage is mediated by the inner
membrane rhomboid protease presenilin-associated rhomboid-like
protein (PARL) [103,104] and other proteases [102]. The 52 kDa proteo-
lytic fragment is rapidly degraded in a proteasome-dependent manner
[99,103].
On depolarized mitochondria, PINK1 can no longer be imported
and accumulates in its unprocessed form (63 kDa) on the outer mi-
tochondrial membrane (Fig. 2B) [98,99,103]. On the outer mem-
brane PINK1 is assembled in a 700 kDa complex that includes also
core components of the Translocase of the Outer membrane (TOM)
complex but not Parkin [105]. However, TOM complex is not re-
quired for PINK1 targeting to mitochondria and subsequent Parkin
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Fig. 2. ThePINK1/Parkinpathway at a glance. A. Schematic diagramof Parkin indicating function
hub for coordinated mitochondrial maintenance. In healthy mitochondria, PINK1 is imported in
drial membrane depolarization, PINK1 is stabilized on the outermitochondrial membrane, activ
ubiquitin chains on several mitochondria-surface molecules simultaneously coordinating mitoc
Presenilin-associated rhomboid-like protein; PINK1, Phosphatase and tensin homolog (PTEN)-compartments that lack TOM complex, like lysosomes or peroxisomes,
is able to induce Parkin recruitment, organelle ubiquitination and clear-
ance by autophagy [105]. Parkin artiﬁcially recruited on mitochondria
without PINK1 can neither ubiquitinate mitochondrial proteins nor
induce autophagic clearance of mitochondria, advocating for a role of
mitochondrial PINK1 in activation of E3 ligase activity of Parkin. Alter-
natively, PINK1 can be stabilized on the outer membrane of healthy
mitochondria when there is excessive unfolded protein load into the
matrix. This signal is enhanced when Lon protease is depleted and
triggers PINK1-Parkin dependent-mitophagy [106,107].
How is Parkin E3 ligase activity stimulated by PINK1? It was shown
that PINK1 becomes activated upon membrane depolarization by auto-
phosphorylation at several sites [108,109]. In turn, activated PINK1
phosphorylates Parkin on conserved Serine-65 of the UblD. Although
this phosphorylation event is not sufﬁcient for mitochondrial transloca-
tion of Parkin, it is proposed to release the auto-inhibition of Parkin
leading to activation of its E3 ligase activity [108,110–112]. RING1
domain of Parkin is important for the physical interaction of Parkin
with PINK1 [110], while RING2 is critical for ubiquitin-thiolester trans-
fer through the formation of an ubiquitin-thioester intermediate on
Cysteine-431 [113,114]. Under basal conditions, RING0 occludes the
ubiquitin-acceptor site Cysteine-431, ensuring autoinhibition of E3
ligase activity [97]. Moreover, Parkin was shown to self-associate in
a PINK1-dependent manner, through its IBR domain. This self-
association is critical for activation of Parkin E3 activity upstream
of its mitochondrial translocation [114]. Interestingly, it was shown
that translocation of Parkin onto damaged mitochondria is stabilized
by physical interaction with its substrates, namely Voltage Depen-
dent Anion Channel (VDAC) and guanosine triphosphate MFN2
[115,116]. Recruitment of Parkin to mitochondria induces rupture
of the outer mitochondrial membrane in a proteasome-dependent
manner. However, the latter is not required for mitophagy [117].
Recent landmark studies report that ubiquitin itself is phosphorylat-
ed by PINK1 on Serine-65, similar to the UblD of Parkin [118–121].
Initially this phosphorylation was proposed to activate the E3 ligase
activity of Parkin. Lately, a different model was proposed, in which
phosphorylation of poly-ubiquitin follows ubiquitin conjugation onto
Parkin substrates [122,123]. Parkin catalyzes the formation of K6, K11,
K27, K48 and K63-linked ubiquitin chains on its substrates [122,124].
The role of each of these different poly-ubiquitin structures in substrate










al domains. Numbers represent amino-acid position. B. The PINK1/Parkinpathway acts as a
to the inner membrane, processed by PARL and subsequently degraded. Upon mitochon-
ated by autophosphorylation, and then recruits and activates Parkin. Activated Parkin adds
hondrial motility, dynamics and recruitment of autophagic machinery components. PARL,
induced putative kinase 1.
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come to modulate Parkin's activity by removing ubiquitin chains from
Parkin itself and from injured mitochondria [125–127].
7.2. Mitochondrial substrates of Parkin
Parkin has a variety of cellular targets through which it regulates
many fundamental cellular pathways involved in cell cycle and survival,
protein aggregation, vesicle trafﬁcking, and cytoskeleton. During
mitophagy, Parkin, following its activation, ubiquitinates mitochondrial
surface proteins usually triggering their degradation by the proteasome.
Interestingly, upon mitophagy induction proteasomes are clustered
onto damaged mitochondria in the perinuclear region [117]. Never-
theless, Parkin-dependent ubiquitination doesn't always lead to
degradation. It is widely accepted that ubiquitinated substrates on
mitochondrial surface tag mitochondria for mitophagy through re-
cruitment of components of the autophagic machinery.
Mitofusins (MFN1/2) are the best characterized example of
ubiquitinated Parkin substrate. MFN1/2 are large GTPases that mediate
mitochondrial fusion. Parkin-dependent ubiquitination of MFN1/2
primes them for degradation by the proteasome in a p97 AAA+
ATPase-dependent manner [101,115,128–130]. It is proposed that
selective degradation of MFN1/2 leads to fragmentation of damaged
mitochondria, which stands as a prerequisite for their engulfment by
autophagosomes. Other outer membrane mitochondrial proteins
targeted for proteasomal degradation by Parkin are components of the
Translocase of the Outer Mitochondrial Membrane (TOM) complex,
such as Tom40, Tom20 and Tom70 as well as Omp25. Proteasomal
degradation of those is not a prerequisite for mitophagy [117].
Miro is a Rho GTPase found on the outer mitochondrial membrane.
Together with its partners, Milton and Kinesin 1 Heavy Chain (KHC) it
serves as an anchor of mitochondria to microtubules, allowing for
rapid mitochondrial translocation. Upon mitophagy, phosphorylation
of Miro by PINK1 leads to its Parkin-dependent proteasomal degrada-
tion rendering impaired mitochondria unable to move [131–133]. This
is particularly relevant in neuronal cells where mitochondria need to
travel long distances along the neuronal axis. Unhooked mitochondrial
are locally removed by autophagy in a PINK1 and Parkin-dependent
manner [134]. This focal response along neuronal axis provides rapid
neuroprotection against mitochondrial stress.
Parkin-dependent ubiquitinylated VDACs are shown to attract
the autophagy scaffold p62/sequestosome 1 (p62/SQSTM1). p62/
SQSTM1 contains a K63-ubiquitin binding domain as well as an LC3
bonding motif through which it targets ubiquitinylated proteins to
autophagosomes [135]. p62/SQSTM1 was proposed to play a role in
PINK1 and Parkin-mediated mitophagy both in mammalian cell linesTable 1
The function of mitophagy-related genes is highly conserved across different taxa.
Model organism
Saccharomyces cerevisiae Caenorhabditis elegans Drosophila melanogaster Mus mu
ATG32 – – –
– dct-1 – Nix/Bnip
– pink1 pink1 PINK1
– pdr-1 parkin Parkin
– fundc-1 (T06D8.7) CG5676 FUNDC1
– sqst-1 (T12G3.1) ref(2)P SQST-1/p
FZO1 fzo-1 fzo, dmfn MFN-1/2
– usp30 (Y67D2.2) usp30 USP30and in D. melanogaster [124,136,137], although this model has been
questioned by other studies showing that p62 is crucial for mitochon-
drial perinuclear aggregation rather than mitophagy [138,139].
7.3. Mitochondria-speciﬁc autophagy receptors
Mitochondrial proteins that recruit components of the autophagic
machinery are considered asmitophagy receptors. Functional homologs
of mitophagy receptors exist from yeast to mammals (Table 1). Two
independent screens for mitophagy-deﬁcient mutants in the budding
yeast revealed Atg32 as a protein essential for respiratory growth-
induced mitophagy in post-log phase cells [140,141]. Atg32 is a
mitochondria-anchor protein with an N-terminal cytoplasmic domain,
a single transmembrane domain and a C-terminal domain facing
mitochondrial intermembrane space. The cytoplasmic domain of
Atg32 contains a tetrapeptide sequence, W/F/YxxL/I, (Atg8-family
Interacting Motif—AIM) which mediates interaction with Atg8. Atg32
acts as a receptor for the recruitment of Atg8, and it physically interacts
with Atg11, the scaffold protein involved in selective types of autophagy
[142]. This interaction is required for mitochondrial degradation al-
though it precedes and is independent of isolation membrane and
autophagosome formation. The C-terminal domain of Atg32 is proc-
essed by i-AAA (ATPases associated with diverse cellular activities)
protease of the inner mitochondrial membrane, Yme1 [143]. Although
dispensable for mitophagy, the exact role of Atg32 C-terminal domain
and the reason for its removal are currently unknown [143]. Atg32
gets phosphorylated at serine-114 and serine-119 by Casein Kinase 2
(CK2) [144,145] and thus it is activated for interaction with Atg11 and
mitophagy induction.
Although mitophagy is a conserved process, Atg32 homologs have
been found so far only in yeast species [146]. Themammalian functional
homologs of Atg32 are also single-spanning transmembrane proteins
on the outer mitochondrial membrane which encompass the classic
tetrapeptide motif, W/F/YxxL/I, mediating interaction with LC3. BCL2
and adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) and its homo-
log NIX/BNIP3L are atypical BH3-only molecules initially characterized
as pro-apoptotic agents with ability to bind Bcl2 and adenovirus E1B
protein [147]. Apart from their role in cell death both proteins have
been shown tomediatemitophagy by attracting LC3/GABARAP proteins
onto mitochondria. NIX/BNIP3L is required for mitochondrial removal
during mitochondrial stress and reticulocyte maturation. Speciﬁcally,
it serves as a mitochondrial receptor for the LIR-dependent recruitment
of LC3/GABARAP proteins to initiate mitophagy [148]. Although NIX is
critical for mitophagy during reticulocyte maturation, mitophagy can
be partly induced even without NIX and also without core autophagic
components like Atg5/Atg7 [149,150] arguing for the operation ofFunction Reference
sculus
Mitophagy receptor; interacts with Atg8 and recruits
autophagic machinery
[74,140,143]
3 Mitophagy receptor; interacts with LC3/GABARAP
and recruits autophagic machinery
[148]
Protein kinase; phosphorylates Ub and recruits Parkin
to mitochondria
[184,204,205]
E3 ubiquitin ligase; ubiquitinates outer membrane
mitochondrial proteins
[184,204,205]
Mitophagy receptor; interacts with LC3/GABARAP
and recruits autophagic machinery upon hypoxia
[154]
62 Adaptor protein; interacts with ubiquitinated
proteins to recruit autophagic machinery
[124,135,138,139,
158,206,207]
Fusion machinery; ubiquitinated by Parkin, MFN1/2
degradation triggers mitophagy
[115,128,208,209]
Deubiquitinating enzyme; reverse Parkin-dependent
ubiquitination in mitochondrial proteins
[125]
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with LC3 mediatingmitophagy induction [151,152]. A link between the
function of BNIP3L/NIX and the Parkin has emerged in D. melanogaster
[153]. Speciﬁcally, BNIP3L is found ubiquitinated by PARK2 (the
D. melanogaster Parkin homolog), a post-translational modiﬁcation
that seems to attract the selective autophagy adaptor protein NBR1
(Neighbor of BRCA1 gene 1-similar to p62/SQSTM1) to promote
mitophagy. BNIP3L together with PARK2 are degraded upon mitochon-
drial depolarization in a lysosomal-dependent manner [153].
A different type of mitophagy receptor was identiﬁed inmammalian
cells. FUNDC1 is highly conserved from D. melanogaster to humans.
It comprises three putative transmembrane domains near the C-
terminus which faces the intermembrane space. Human FUNDC1 is
localized exclusively on the outermitochondrialmembrane and it inter-
acts with LC3 in a LIR-dependent manner, during hypoxia-induced
mitophagy [154]. FUNDC1 interaction with LC3 is controlled by phos-
phorylation and dephosphorylation events. Speciﬁcally, phosphoryla-
tion of serine-17 by ULK1 as well as dephosphorylation of Serine-13
by PGAM5 phosphatase enhances LC3-binding capacity of FUNDC1
upon hypoxia, which is reversed by CK2-mediated phosphorylation
[155,156]. Finally, expression of mitophagy receptors FUNDC1 and NIX
is regulated by hypoxia-responsive microRNA-137 [157]. miR-137 at-
tenuates expression of FUNDC1 and NIX and thus hypoxia-induced
mitophagy. The reason behind this seemingly contradictory role is not
understood.
Recently, a newmechanism of p62/SQSTM1 attraction onto dam-
aged mitochondria was proposed through direct interaction of p62/
SQSTM1 with choline dehydrogenase (CHDH). CHDC is a mitochon-
drial enzyme residing on both the outer and inner mitochondrial
membranes [158]. CHDHwas not found ubiquitinated uponmembrane
potential disruption. Nevertheless, it was reported to accumulate on the
outer mitochondrial membrane of depolarized mitochondria, indepen-
dently of Parkin, and to form a ternary complex with p62/SQSTM1 and
LC3 to drive mitophagy [158].
8. Mitophagy in neurons and age-associated neurodegeneration
Neurons contain increasedmitochondrial population, since highATP
levels are demanded to carry out their functions and preserve neuronal
homeostasis [159]. Because of the unique neuronal architecture, which
is characterized by relative small cell body, long axons and multiple
dendritic branches, neurons are equippedwith specializedmechanisms
for efﬁcient distribution of mitochondria to distal regions, such as pre-
synaptic endings, postsynaptic densities, axonal branches and growth
cones, where high energy is required to sustain neuronal activity [160].
Post-mitotic neuronal cells must survive during the lifetime of the
organism and they are more vulnerable to the process of ageing due
to their intensive metabolism and increased ROS generation. Therefore,
neuronal activity and survival depend on mitochondrial homeostasis.
Dysfunctional mitochondria not only produce less ATP but also display
impaired buffering of cytosolic calcium. Furthermore, elevated ROS pro-
duction can trigger neuronal stress and lead to neurodegeneration
[159]. Thus, aged or damaged mitochondria need either to be repaired
throughmitochondrial quality controlmechanisms, such as proteasome
system,mitochondrial proteases and ﬁssion–fusionmachinery, or elim-
inated by mitophagy.
Neuronal mitochondrial degradation is a challenging cellular event
since the majority of mitochondrial mass is located at the distal neuro-
nal processes, far away from the cell body of the neuron, where mature
acidic lysosomesmainly exist [161–163]. Despite the spatial limitations,
rapid elimination of dysfunctional mitochondria is essential for neuro-
nal protection against cell death. Indeed, basal autophagy is critical for
the maintenance of axons and dendrites since insufﬁcient or excessive
autophagy causes neuritic degeneration [164–166]. Autophagy deﬁ-
ciency could also lead to protein aggregation, a hallmark of several neu-
rological disorders such as Parkinson's disease, Alzheimer's disease andHuntington's disease. Conversely, autophagy stimulation has a protec-
tive effect against proteinopathies through effective clearance of
misfolded and aggregated proteins. Additionally, defective autophagic
elimination of damaged mitochondria may contribute to oxidative
stress and initiate apoptotic or necrotic cell death in neurons [167–170].
Depolarized mitochondria are characterized by altered motility
since they present reduced anterograde and relatively enhanced retro-
grade transport. Thus, healthy mitochondrial population remains in
the distal parts of the neuron and damaged mitochondria are trans-
ferred and eliminated in the neuronal cell body (Fig. 3) [171–173].
This model is consistent with the ﬁndings of several studies showing
that Miro, a mitochondrial adaptor protein anchoring the kinesin
motor complex to mitochondria, is degraded in a PINK1/Parkin-
dependent manner upon mitochondrial depolarization [132,174–179].
In turn, mitochondria are transported to the soma of the neuron or are
immobilized at neuronal axons and dendrites for mitophagy. The fact
that autophagosomal maturation requires acidic lysosomes indicates
that damaged mitochondria are engulfed locally by autophagosomes
and then retrieved to the soma for destruction [175,176,180]. In addi-
tion to the autophagosome formation in the axons, the retrograde
movement of mitoautophagosomes, which are autophagosomes con-
taining dysfunctional or aged mitochondria, has been reported [175].
A recent study has revealed an additional cell non-autonomous mecha-
nism for distal mitochondrial degradation named as transcellular
mitophagy or transmitophagy (Fig. 3). A mitochondrial population of
the retinal ganglion cell monitored to be diminished by the optic
nerve head astrocytes [181]. The elucidation of transmitophagy opens
new avenues in the ﬁeld of neuronal mitochondrial autophagy
underlining the importance of investigating whether other neurons
with long-projecting processes adapt transcellular mitophagy as the
main quality control mechanism of mitochondrial elimination under
physiological or pathological conditions.
Accumulating evidence signiﬁes the maintenance of mitochondrial
homeostasis since mitochondrial dysfunction, altered dynamics, defec-
tive transport and impaired mitochondrial degradation are associated
with the onset and the progression of several age-associated neurode-
generative diseases such as Parkinson's disease, Alzheimer's disease
and Huntington's disease [32,87,182,183].
8.1. Parkinson's disease
Loss of dopaminergic neurons in the substantia nigra, a region essen-
tial for motor control and coordination, is the major hallmark of
Parkinson's disease. PINK1 and PARK2 genes have been linked with the
hereditary forms of parkinsonism. Interestingly, the function of both
genes is involved in the maintenance of healthy mitochondrial popula-
tion. Several studies unravel the role of the PINK1/Parkin pathway in the
elimination of dysfunctional mitochondria through the process of
mitophagy [184]. Additionally, Parkinson's disease patients contain
mtDNA mutations and/or deletions more frequent compared to aged-
matched individuals. Such mutations of mtDNA accumulate during
ageing in the neuronal cells of substantia nigra and causemitochondrial
damage [185,186]. Consistently, there is a correlation between dopami-
nergic neuronal loss and accumulation of mitochondrial damage in the
development and progression of Parkinson's disease. Hence, environ-
mental toxins, mtDNA defects and impairment of mitophagy could
lead to excessive mitochondrial stress and might also contribute to the
pathogenesis of Parkinson's disease [187]. However, it is still unclear
whether the PINK1/Parkin pathway orchestrates mitophagy and pre-
serves mitochondrial homeostasis in neurons under steady-state condi-
tions. Mitophagy process has been delineated in non-neuronal cells,
with Parkin function remaining controversial and obscure in neurons.
A few studies report that mitochondrial impairment does not trigger
Parkin translocation [188,189]. On the contrary, other studies show
that depolarized mitochondria are engulfed by autophagosomes in



















Fig. 3. Themechanisms of neuronal mitophagy. Dysfunctional mitochondria trigger PINK1/Parkin-dependent mitophagy. PINK1 accumulation on outermitochondrial membrane recruits
the cytosolic E3 ubiquitin ligase Parkin. Parkin-targeted mitochondria are engulfed by autophagosomes. Damaged mitochondria or mitoautophagosomes are transported from the distal
regions to the soma of the neuron, where acidic lysosomes are mainly located. Therefore, dysfunctional mitochondria display altered motility with reduced anterograde and enhanced
retrograde movement. Kinesin and dynein motor proteins promote anterograde and retrograde movement respectively. Additionally, axonal mitochondria could be removed
by neighboring astrocytes through the process of trans-cellular mitophagy.
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neuroprotection during ageing [191]. Recently, it is found that
deubiquitinating enzymes, such as USP15 and USP30 oppose and re-
verse the function of Parkin on mitochondrial proteins [125,126]. In-
hibition of deubiquitinases enhances mitophagy in healthy neurons.
Additionally, USP30 depletion results in increased survival, de-
creased dopamine loss and behavioral defects [125]. These ﬁndings
indicate that impairing the balance between ubiquitination and
deubiquitination events either on mitochondrial substrates [125] or
on Parkin protein per se [127], might lead to elevated mitochondrial
dysfunction and subsequently loss of dopaminergic neurons. Thus, fur-
ther work is needed to clarify the role of PINK1/Parkin pathway in vivo
in neurons, especially in pathological conditions or during ageing.
8.2. Alzheimer's disease
Alzheimer's disease is themost common age-related neurodegener-
ative disorder. Death of neurons in the cerebral cortex results in cogni-
tive dysfunction and loss of memory, two hallmarks of Alzheimer's
disease pathogenesis. Although the mechanisms that lead to the devel-
opment and progression of Alzheimer's disease remain unclear, the pri-
mary hypothesis is that accumulation of beta-amyloids (Aβ) derivedfrom amyloid precursor protein (APP) causes cellular defects and toxic-
ity. Emerging evidence implicatesmitochondrial dysfunction and defec-
tivemitophagy in Alzheimer's disease pathogenesis [192]. Elevated ROS
production upon mitochondrial damage affects the function of several
mitochondrial components including membrane lipids, electron trans-
port chain complex proteins and mtDNA. Deﬁciency of mitochondrial
complexes I and IV is associated with enhanced tau toxicity and Aβ
accumulation [193]. Furthermore, the existence of autophagic vacuoles
in neurons of Alzheimer's disease patients indicates the implication of
non-selective and/or selective autophagy in disease development
[194]. Concluding, elimination of impaired mitochondria through
mitophagy might be beneﬁcial for maintenance of mitochondrial ho-
meostasis and defense against Alzheimer's disease.
8.3. Huntington's disease
Huntington's disease is an autosomal dominant neurodegenerative
disorder. The aberrant expansion of cytosine, adenosine and guanine
(CAG) repeats within the huntingtin gene is the main cause of disease
pathology. The number of CAG repeats correlates with the severity of
the disease. Cytoplasmic and nuclear aggregates of mutant huntingtin
protein are the major pathological hallmark of Huntington's disease
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to neuronal disability and death. Impaired mitochondrial function and
oxidative stress have been associated with the accumulation of mutant
huntingtin. Altered mitochondrial morphology, motility, energy deple-
tion, insufﬁcient cytoplasmic calcium buffering capacity and impair-
ment of membrane potential are some of the reported mitochondrial
defects inHuntington's disease patients [196–198]. Notably, stimulation
of peroxisome proliferator-activated receptor gamma coactivator-1α
(PGC-1α), which orchestrates the process of mitochondrial biogenesis,
alleviates neuronal dysfunction by promoting the activation of tran-
scription factor EB (TFEB) and preventing oxidative stress [199–201].
TFEB is the master regulator of lysosomal and autophagy genes [202].
Therefore, mitophagy induction and degradation of damaged mito-
chondria might be beneﬁcial and protective against the neuronal
loss in Huntington's disease. Indeed, enhancing mitophagy by overex-
pressing PINK1 promotes neuroprotection against mutant huntingtin
toxicity. PINK1 overexpression rescues the abnormal mitochondrial
morphology, ATP levels and enhances survival of ﬂies expressing mu-
tant huntingtin in neurons [203]. Furthermore, mutant huntingtin
does not affect the recruitment of Parkin on damaged mitochondria
but diminishes the engulfment of mitochondria by autophagosomes
[203]. These ﬁndings are consistent with a previous study showing
that autophagic cargo recognition is defective in Huntington's disease
and leads to accumulation of dysfunctional mitochondria in the cyto-
plasm [183]. Thus, enhancing mitophagy could sustain mitochondrial
function and lead to neuroprotection in Huntington's disease.
9. Concluding remarks
Themaintenance of a healthymitochondrial population is crucial for
cellular and organismal homeostasis. Post-mitotic neuronal cells are
more susceptible to mitochondrial damage due to their increased
metabolic demands. Therefore, effective mitochondrial quality control
is pivotal for neuronal functionality. Despite the fact that molecular
mechanismsofmitochondrial selective autophagy have been extensive-
ly studied, several controversial questions remain to be answered about
neuronal mitophagy. The stimulus and the molecular mechanisms,
which regulate autophagosomal formation in axons, cargo recognition
and sequestration, transport to the soma, fusion with lysosomes and
degradation are still unclear. Moreover, the mechanisms that regulate
the interplay between autophagy, apoptosis and necrotic cell death in
axonal and dendrite degeneration remain unknown. Unraveling potent
mitophagy-inducing compounds and understanding how mitophagy
protects against neuronal deathwould be essential for the development
of novel and context-speciﬁc pharmacological interventions against
neurodegenerative disorders.
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